Stryker Biotech (Bone Morphogenetic Protein Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Stryker Biotech (Bone Morphogenetic Protein Business) General Information

Description

Developer of bone protein. The company is engaged in developing bone morphogenetic protein for treatment of long bone fractures and and lumbar spine fusion.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Corporate Office
  • 2825 Airview Boulevard
  • Portage, MI 49002
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stryker Biotech (Bone Morphogenetic Protein Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stryker Biotech (Bone Morphogenetic Protein Business)‘s full profile, request access.

Request a free trial

Stryker Biotech (Bone Morphogenetic Protein Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Stryker Biotech (Bone Morphogenetic Protein Business)‘s full profile, request access.

Request a free trial

Stryker Biotech (Bone Morphogenetic Protein Business) FAQs

  • Where is Stryker Biotech (Bone Morphogenetic Protein Business) headquartered?

    Stryker Biotech (Bone Morphogenetic Protein Business) is headquartered in Portage, MI.

  • What industry is Stryker Biotech (Bone Morphogenetic Protein Business) in?

    Stryker Biotech (Bone Morphogenetic Protein Business)’s primary industry is Biotechnology.

  • Is Stryker Biotech (Bone Morphogenetic Protein Business) a private or public company?

    Stryker Biotech (Bone Morphogenetic Protein Business) is a Private company.

  • What is the current valuation of Stryker Biotech (Bone Morphogenetic Protein Business)?

    The current valuation of Stryker Biotech (Bone Morphogenetic Protein Business) is 0000.

  • What is Stryker Biotech (Bone Morphogenetic Protein Business)’s current revenue?

    The current revenue for Stryker Biotech (Bone Morphogenetic Protein Business) is 000000.

  • Who are Stryker Biotech (Bone Morphogenetic Protein Business)’s investors?

    Stryker has invested in Stryker Biotech (Bone Morphogenetic Protein Business).

  • When was Stryker Biotech (Bone Morphogenetic Protein Business) acquired?

    Stryker Biotech (Bone Morphogenetic Protein Business) was acquired on 01-Feb-2011.

  • Who acquired Stryker Biotech (Bone Morphogenetic Protein Business)?

    Stryker Biotech (Bone Morphogenetic Protein Business) was acquired by Olympus (Diagnostic Equipment).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »